Engineering - Bioprocess Engineering
The Master of Science (M.Sc.) in Bioprocess Engineering is delivered by DCU's School of Biotechnology in conjunction with TCD School of Pharmacy and Pharmaceutical Sciences and the National Institute for Bioprocessing Research and Training (NIBRT). It is accredited by DCU.
The M.Sc. is an interactive and dynamic programme that will develop your knowledge and appreciation of the conceptual and factual bases for bioprocess design and operation. It also develops your understanding of bioprocessing, particularly the structures, roles and experimental methods associated with biopharmaceuticals, their analysis, production methods and technology for monitoring and control of bioprocesses.
It provides an advanced and up-to-date academic base in the major disciplines of bioprocess engineering and fosters a range of transferable skills across a full range of relevant subjects.
The course is delivered on-line using DCU's LOOP virtual environment. Lectures are released on Monday and Friday of each week, they will be a mixture of live Zoom sessions and lecture recordings. Also all material is recorded for later access at a time that suits you. Each year, in Semester 2 there is a week-long laboratory session held in NIBRT. On completion of 12 modules you will complete a dissertation on a bioprocessing related topic. We welcome full-time and part-time students to the course.
This course has been designed to:
Update and upgrade the knowledge, understanding and skills of graduates who are interested in pursuing or are currently working in the Biopharmaceutical industry.
Retrain graduates working in related disciplines, by providing advanced level modules in the theory, analysis design and practical methodology of the rapidly evolving subjects that are associated with this sector.
Part-time students can complete the course anytime within a four year period, however we recommend that you take the course over two years. To complete the course within this time-frame, you should take three taught modules each semester and complete the dissertation project during a summer semester. The dissertation module opens during March each year, you may start it on the completion of six taught modules.
All taught modules are self-contained and independent of each other. You may choose modules in any order you wish, however we recommend taking BE517, BE515, BE587 & BE560 in the first year as they offer a grounding in the course.
The programme has an excellent reputation in the biopharmaceutical industry, with a number of companies (Eli Lilly, Pfizer, Merck, BMS) registering employees for the full or partial programme.
This post-graduate programme builds on the world-renowned experience of the course presenters, including professors, lecturers and industrial experts.
The programme provides a platform for entry into research-level positions (PhD, further specialised programmes) and industries involved in the production of recombinant therapeutic proteins/diagnostics.
It also provides a highly interactive environment for the understanding of real bioprocesses, and to encourage discussion with industry experts in a dynamic environment, on actual problems and challenges in the bioprocessing sector.
To view the current course structure, please visit the Provider's website.
General Entry Requirements
This programme is targetted at industry based students or anyone who wishes to move from small mocule manfacturing to bio-pharma. For example, in cases where a student has more than three years industry experience in a related field.
• The programme will be open to graduates and those currently working in industry with an honours degree (minimum second class honours grade 2) in Science or Engineering.
• Applicants who do not hold an honours degree but who have significant relevant industrial experience will also be considered, and should contact the Programme Chair to discuss this prior to applying.
• International candidates who are non-native speakers of English must satisfy the University of their competency in the English language.
To apply for this programme:
All applicants should apply through https://dcuie.elluciancrmrecruit.com/Apply/.
Provide Academic Transcripts for each and every year of study with English translation if applicable.
Provide a brief statement outlining your motivation for doing the programme, including details of your relevant industrial experience.
Provide a copy of your CV.
If applicable, provide evidence of competence in the English language as per DCU entry requirements. Please see link http://www.dcu.ie/registry/english.shtml.
Please note if you are a non EU student and require a study visa, you are not eligible to apply for part-time programmes as study visas are only granted for full-time programmes.
Applications will be accepted on a rolling basis until the programme is full or until:
- Closing date for non EU applicants is 1st July 2022.
- Closing date for EU applicants is 31st July 2022.
Note applicants who require a study visa for the purposes of studying at DCU, are advised to apply as early as possible.
All entry requirements should be met before the commencement of the programme.
Queries from EU applicants should be directed to email@example.com
Queries from non EU applicants should be directed to firstname.lastname@example.org
Full Time - 1 Year, Part Time - continuous min 1 year.
DC735 (Full-Time) & DC734 (Part-Time).
Commencement of Programme
The programme commences in September 2022.
Post Course Info
As a MSc graduate you will be able to further your career with a thorough understanding of best-practice in Ireland's rapidly-growing biopharmaceutical industry. This is a highly skilled sector and graduates are in demand by all companies in the biopharmaceutical industry. It will also help you to advance your career with your current employer.